Max Robotics — Global Service Robot Directory + US Certification

About

F. Schanne is a urologic surgeon whose research centers on the oncologic outcomes of robot-assisted radical cystectomy (RARC) for bladder cancer. As a key contributor to the International Robotic Cystectomy Consortium, Schanne has helped establish the evidence base for minimally invasive surgical approaches in high-risk urologic oncology. Their most cited work, "PE67: Early oncologic failure after robot-assisted radical cystectomy: Results from the international robotic cystectomy consortium" (2014), with 3 citations, was among the first multicenter studies to systematically evaluate early recurrence patterns following RARC, providing critical benchmarks for surgical quality and patient counseling. Schanne also co-authored a reply (2019, 2 citations) in the *Journal of Urology* addressing long-term oncologic outcomes from the same consortium, reinforcing the durability of RARC in experienced hands. While their citation counts are modest, Schanne’s contributions are foundational to the growing body of evidence supporting robotic cystectomy, particularly in defining failure modes and refining patient selection. Their work remains a reference point for surgeons and researchers seeking to optimize outcomes in bladder cancer surgery.